search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

Compliance with periodic surveillance for Von-Hippel-Lindau disease.

Chantal R M Lammens ,
Neil K Aaronson ,
Frederik J Hes ,
Thera P Links ,
Bernard A Zonnenberg ,
Jacques W M Lenders ,
Danielle Majoor-Krakauer ,
Theo A M Van Os ,
Encarna B Gomez-Garcia ,
Wouter de Herder ,
Rob B van der Luijt ,
Ans M W van den Ouweland ,
Liselot P Van Hest ,
Senno Verhoef ,
Eveline M A Bleiker

Abstract

METHODS

In this nationwide study, Von Hippel-Lindau disease mutation carriers and those at 50% risk were invited to complete a questionnaire assessing (compliance with) advice given for periodic surveillance. Medical record data on compliance with recommended radiologic surveillance examinations were also collected.

CONCLUSIONS

The majority of those with or at risk of Von Hippel-Lindau disease reported having received and being fully compliant with screening advice. However, in many cases, the advice given was only partially consistent with published guidelines, and screening delays were observed. Efforts should be undertaken to stimulate guideline-based surveillance advice and to minimize screening delay.

RESULTS

Of the 84 (77%) participants, 78 indicated having received advice to undergo periodic surveillance. Of these, 71 reported being fully compliant with that advice. In 64% of the cases, this advice was only partially consistent with published guidelines. Based on medical record data, between one quarter and one third of individuals did not undergo surveillance as recommended in the guidelines for central nervous system lesions and one half for visceral lesions. Screening delay for central nervous system lesions was significantly higher in one hospital and in those cases where "the advice given" deviated from the guidelines.

PURPOSE

To assess compliance with a periodic surveillance regimen for Von Hippel-Lindau disease.

More about this publication

Genetics in medicine : official journal of the American College of Medical Genetics

Volume 13
Issue nr. 6
Pages 519-27
Publication date 01-06-2011

Full text links

Publisher website (DOI) 10.1097/GIM.0b013e3182091a1d
Europe PubMed Central 21415761
Pubmed 21415761

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.